Literature DB >> 30963320

Always randomize as late as possible.

Erik van Werkhoven1, Parvin Tajik2, Patrick M Bossuyt3.   

Abstract

Mesh:

Year:  2019        PMID: 30963320     DOI: 10.1007/s10120-019-00959-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  6 in total

1.  Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

Authors:  Annemieke Cats; Edwin P M Jansen; Nicole C T van Grieken; Karolina Sikorska; Pehr Lind; Marianne Nordsmark; Elma Meershoek-Klein Kranenbarg; Henk Boot; Anouk K Trip; H A Maurits Swellengrebel; Hanneke W M van Laarhoven; Hein Putter; Johanna W van Sandick; Mark I van Berge Henegouwen; Henk H Hartgrink; Harm van Tinteren; Cornelis J H van de Velde; Marcel Verheij
Journal:  Lancet Oncol       Date:  2018-04-09       Impact factor: 41.316

2.  When to randomize?

Authors:  S Durrleman; R Simon
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

3.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

4.  Pragmatic Trials.

Authors:  Ian Ford; John Norrie
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

5.  Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.

Authors:  Y H M Claassen; H H Hartgrink; W O de Steur; J L Dikken; J W van Sandick; N C T van Grieken; A Cats; A K Trip; E P M Jansen; W M Meershoek-Klein Kranenbarg; J P B M Braak; H Putter; M I van Berge Henegouwen; M Verheij; C J H van de Velde
Journal:  Gastric Cancer       Date:  2018-09-20       Impact factor: 7.370

6.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.